Home › Companies › NUVATION BIO INC. › 2024-2025

NUVATION BIO INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and NUVATION BIO INC.’s Form 8-K, filed September 5, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.

8Ballot items
169Asset managers
1,472Fund votes
September 3, 2024Main meeting date

Results at a glance

Meeting of September 3, 2024: 5 items on NUVATION BIO INC.’s Form 8-K, filed September 5, 2024: 1 elected · 4 approved.

Meeting of May 21, 2025: 3 items on NUVATION BIO INC.’s Form 8-K, filed May 23, 2025: 1 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore NUVATION BIO INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by NUVATION BIO INC.

These tallies are NUVATION BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed September 5, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. NUVATION BIO INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

NUVATION BIO INC. — official shareholder meeting results, meeting held September 3, 2024 (Form 8-K, filed September 5, 2024)
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Min Cui, Ph.D.	210,137,812	--	--	742,967	20,585,212	99.6%	Elected	—
2. Ratification of Independent Registered Public Accounting Firm	231,131,143	217,489	117,359	--	0	99.9%	Approved	—
3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement	208,479,505	1,832,719	568,555	--	20,585,212	99.1%	Approved	—
4. To approve conversion of the outstanding shares of Series A Non-Voting Convertible Preferred Stock to Class A Common Stock	179,742,172	2,919,589	572,763	--	20,585,212	98%	Approved	—
5. To approve an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies	222,804,900	8,550,665	110,426	--	0	96%	Approved	—

Source: NUVATION BIO INC., Form 8-K, filed with the SEC on September 5, 2024 — read the filing on EDGAR.

NUVATION BIO INC. — official shareholder meeting results, meeting held May 21, 2025 (Form 8-K, filed May 23, 2025)
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Kathryn E. Falberg	198,624,124	--	--	18,024,599	64,812,107	92%	Elected	—
2. Ratification of Independent Registered Public Accounting Firm	279,883,301	1,561,729	15,800	--	0	99.4%	Approved	—
3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement	214,903,033	1,601,869	143,821	--	64,812,107	99.2%	Approved	—

Source: NUVATION BIO INC., Form 8-K, filed with the SEC on May 23, 2025 — read the filing on EDGAR.

How asset managers voted at the NUVATION BIO INC. 2024-2025 meetings

Each item below shows how the 169 asset managers that disclosed a NUVATION BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Min Cui, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held September 3, 2024.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 210,137,812WITHHELD: 742,967

Details: description as filed, official tally, votes by 48 asset managers

Description as filed by funds: Election of Director: Min Cui, Ph.D.

NUVATION BIO INC.’s own tally for this item (“Elect Director: Min Cui, Ph.D.”): 210,137,812 for, 742,967 withheld, per its Form 8-K filed September 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 47,615,258 for.

FOR

FOR: 47,615,258

Largest asset managers voting on “Election of Director: Min Cui, Ph.D.” at NUVATION BIO INC., 2024-2025
Asset manager	For	Vote
Fidelity	21,071,540	For
Vanguard	9,999,264	For
BlackRock	8,255,183	For
TIAA	1,896,048	For
Charles Schwab	1,347,201	For
Dimensional	830,105	For
Equitable	420,669	For
Federated Hermes	361,146	For
QUANTITATIVE MASTER SERIES LLC	357,839	For
State Street	305,855	For
American Century	269,297	For
Nationwide	269,106	For
SEI	246,583	For
Columbia Threadneedle	234,030	For
Lincoln Financial	220,418	For
Northern Trust	137,534	For
Thrivent	107,961	For
Global X	98,817	For
AIG/SunAmerica	96,552	For
ETF Series Solutions	89,606	For
Invesco	82,454	For
Pacific Life	81,819	For
T. Rowe Price	81,560	For
Bridge Builder Trust	81,302	For
John Hancock	78,125	For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

2. Elect Director: Kathryn E. Falberg

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Meeting held May 21, 2025.

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%

FOR: 198,624,124WITHHELD: 18,024,599

Details: description as filed, official tally, votes by 41 asset managers

Description as filed by funds: Election of Director: Kathryn E. Falberg

NUVATION BIO INC.’s own tally for this item (“Elect Director: Kathryn E. Falberg”): 198,624,124 for, 18,024,599 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 41 asset managers below reported 49,940,769 for, 7,195,385 withheld, 562,415 abstained.

FOR

FOR: 49,940,769ABSTAIN: 562,415WITHHOLD: 7,195,385

Largest asset managers voting on “Election of Director: Kathryn E. Falberg” at NUVATION BIO INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Fidelity	27,142,962	0	4,489,865	Mixed
Vanguard	14,991,135	0	0	For
BlackRock	4,573,037	411,202	0	Mixed
Charles Schwab	1,898,919	0	0	For
Dimensional	0	0	1,030,309	Withhold
Equitable	317,573	0	197,389	Mixed
American Century	0	0	481,171	Withhold
TIAA	0	0	407,068	Withhold
Northern Trust	301,765	0	0	For
SEI	210,185	0	0	For
Invesco	172,341	0	0	For
Lincoln Financial	0	0	134,500	Withhold
Global X	108,429	0	0	For
Pacific Life	91,871	0	0	For
Bridge Builder Trust	81,302	0	0	For
ProShares	0	0	80,215	Withhold
ETFis Series Trust I	0	0	62,421	Withhold
ETF Series Solutions	0	51,266	0	Abstain
Brighthouse	0	0	50,799	Withhold
John Hancock	0	42,525	0	Abstain
State Street	33	0	36,937	Withhold
Direxion Shares ETF Trust	0	0	33,576	Withhold
Nationwide	31,679	0	0	For
Jackson National	0	29,713	0	Abstain
DWS	0	0	28,322	Withhold

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

3. 4. To approve conversion of the outstanding shares of Series A Non-Voting Convertible Preferred Stock to Class A Common…

Official resultCAPITAL STRUCTUREReported outcome: Approved

Meeting held September 3, 2024.

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 179,742,172AGAINST: 2,919,589

Details: description as filed, official tally, votes by 48 asset managers

Description as filed by funds: To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class A Common Stock.

NUVATION BIO INC.’s own tally for this item (“4. To approve conversion of the outstanding shares of Series A Non-Voting Convertible Preferred Stock to Class A Common Stock”): 179,742,172 for, 2,919,589 against — passed, per its Form 8-K filed September 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved for the purpose of complying with the listing rules of the New York Stock Exchange (NYSE), the issuance of up to 85,120,200 shares of Class A Common Stock upon conversion of Series A Non-Voting Convertible Preferred Stock issued in April 2024.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 48 asset managers below reported 47,155,711 for, 459,547 against.

FOR

FOR: 47,155,711AGAINST: 459,547

Largest asset managers voting on “To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class ” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	21,071,540	0	For
Vanguard	9,999,264	0	For
BlackRock	8,255,183	0	For
TIAA	1,896,048	0	For
Charles Schwab	1,347,201	0	For
Dimensional	830,105	0	For
Equitable	420,669	0	For
Federated Hermes	361,146	0	For
QUANTITATIVE MASTER SERIES LLC	357,839	0	For
State Street	689	305,166	Against
American Century	269,297	0	For
Nationwide	269,106	0	For
SEI	246,583	0	For
Columbia Threadneedle	234,030	0	For
Lincoln Financial	77,918	142,500	Mixed
Northern Trust	137,534	0	For
Thrivent	107,961	0	For
Global X	98,817	0	For
AIG/SunAmerica	96,552	0	For
ETF Series Solutions	89,606	0	For
Invesco	82,454	0	For
Pacific Life	81,819	0	For
T. Rowe Price	81,560	0	For
Bridge Builder Trust	81,302	0	For
John Hancock	78,125	0	For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

4. 5. To approve an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Meeting held September 3, 2024.

96% Approved · of votes cast

FOR 96%

FOR: 222,804,900AGAINST: 8,550,665

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies.

NUVATION BIO INC.’s own tally for this item (“5. To approve an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies”): 222,804,900 for, 8,550,665 against — passed, per its Form 8-K filed September 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 46,548,095 for, 998,934 against.

FOR

FOR: 46,548,095AGAINST: 998,934

Largest asset managers voting on “To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies.” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	21,071,540	0	For
Vanguard	9,999,264	0	For
BlackRock	8,255,183	0	For
TIAA	1,896,048	0	For
Charles Schwab	1,347,201	0	For
Dimensional	830,105	0	For
Equitable	420,669	0	For
Federated Hermes	361,146	0	For
QUANTITATIVE MASTER SERIES LLC	357,839	0	For
State Street	689	305,166	Against
American Century	269,297	0	For
Nationwide	259,374	9,732	For
SEI	0	246,583	Against
Columbia Threadneedle	234,030	0	For
Lincoln Financial	77,918	142,500	Mixed
Northern Trust	137,534	0	For
Thrivent	107,961	0	For
Global X	0	98,817	Against
AIG/SunAmerica	96,552	0	For
ETF Series Solutions	89,606	0	For
Invesco	82,454	0	For
Pacific Life	81,819	0	For
T. Rowe Price	0	81,560	Against
Bridge Builder Trust	81,302	0	For
John Hancock	78,125	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the…

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Meeting held September 3, 2024.

Combines 6 wordings of this item as funds reported it.

99.1% Approved · of votes cast

FOR 99.1%

FOR: 208,479,505AGAINST: 1,832,719

Details: description as filed, official tally, votes by 131 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

NUVATION BIO INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 208,479,505 for, 1,832,719 against — passed, per its Form 8-K filed September 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 46 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	21,071,540	0	For
Vanguard	9,999,264	0	For
BlackRock	8,255,183	0	For
TIAA	1,643,608	0	For
Charles Schwab	1,347,201	0	For
Dimensional	830,105	0	For
Federated Hermes	361,146	0	For
QUANTITATIVE MASTER SERIES LLC	357,839	0	For
State Street	305,817	38	For
American Century	0	269,297	Against
Nationwide	252,495	0	For
Equitable	235,530	0	For
Columbia Threadneedle	234,030	0	For
Lincoln Financial	220,418	0	For
SEI	139,240	0	For
Northern Trust	137,534	0	For
Thrivent	107,961	0	For
Global X	98,817	0	For
AIG/SunAmerica	96,552	0	For
ETF Series Solutions	89,606	0	For
Invesco	0	82,454	Against
Pacific Life	81,819	0	For
T. Rowe Price	81,560	0	For
Bridge Builder Trust	81,302	0	For
John Hancock	78,125	0	For

Fund voting reports, all 46 managers: 46,646,702 for, 370,649 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 101 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	28,955,133	0	For
EcoR1 Capital, LLC	13,844,016	0	For
BlackRock	4,771,292	17,733	For
GEODE CAPITAL MANAGEMENT, LLC	3,968,417	0	For
ABRAMS CAPITAL MANAGEMENT, L.P.	3,811,513	0	For
Octagon Capital Advisors LP	2,984,013	0	For
State Street	2,679,549	1,334	For
Aisling Capital Management LP	2,541,009	0	For
Citadel	1,927,360	0	For
Nuveen	1,901,472	0	For
Charles Schwab	1,347,502	0	For
Northern Trust	1,212,435	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	892,162	0	For
MELLON INVESTMENTS Corp	752,871	0	For
Two Sigma	569,184	0	For
Wellington	515,002	0	For
Clearline Capital LP	437,237	0	For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	387,342	0	For
Federated Hermes	362,881	0	For
JPMorgan	352,741	0	For
Vanguard	349,362	0	For
T. Rowe Price	338,195	0	For
American Century	0	269,297	Against
SEI	246,738	0	For
Connor, Clark & Lunn Investment Management Ltd.	210,357	0	For

Institutional-manager reports, all 101 managers: 77,813,534 for, 683,124 against. Showing the 25 largest; see all in the interactive database.

6. 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the…

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Meeting held May 21, 2025.

Combines 9 wordings of this item as funds reported it.

99.2% Approved · of votes cast

FOR 99.2%

FOR: 214,903,033AGAINST: 1,601,869

Details: description as filed, official tally, votes by 122 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.

NUVATION BIO INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 214,903,033 for, 1,601,869 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports: 38 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	31,632,827	0	0	For
Vanguard	14,976,973	0	0	For
BlackRock	4,633,168	0	0	For
Charles Schwab	1,898,919	0	0	For
Dimensional	1,030,309	0	0	For
Equitable	514,962	0	0	For
American Century	0	448,690	0	Against
TIAA	407,068	0	0	For
Northern Trust	301,765	0	0	For
SEI	210,185	0	0	For
Invesco	0	172,341	0	Against
Lincoln Financial	134,500	0	0	For
Global X	108,429	0	0	For
Pacific Life	91,871	0	0	For
ProShares	80,215	0	0	For
ETFis Series Trust I	62,421	0	0	For
ETF Series Solutions	51,266	0	0	For
Brighthouse	41,862	0	8,937	Mixed
John Hancock	42,525	0	0	For
State Street	36,970	0	0	For
Direxion Shares ETF Trust	33,576	0	0	For
Nationwide	31,679	0	0	For
Jackson National	29,713	0	0	For
DWS	28,322	0	0	For
MASTER INVESTMENT PORTFOLIO	27,709	0	0	For

Fund voting reports, all 38 managers: 56,564,135 for, 623,233 against, 8,937 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 100 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN T” at NUVATION BIO INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	47,267,848	0	For
Decheng Capital LLC	0	0	--
Omega Fund Management, LLC	13,072,340	0	For
GEODE CAPITAL MANAGEMENT, LLC	5,089,524	0	For
BlackRock	5,016,722	19,773	For
MPM BioImpact LLC	3,499,122	0	For
Laurion Capital Management LP	3,134,606	0	For
Redmile Group, LLC	3,031,009	0	For
Octagon Capital Advisors LP	2,633,504	0	For
State Street	1,955,194	1,131	For
Charles Schwab	1,899,239	0	For
Citadel	1,535,121	0	For
Northern Trust	951,424	0	For
UBS	571,621	286,664	Mixed
Palo Alto Investors LP	772,652	0	For
Two Sigma	642,302	0	For
Exome Asset Management LLC	555,376	0	For
Vanguard	525,852	0	For
Wellington	502,872	0	For
American Century	0	481,171	Against
Nuveen	412,492	0	For
JPMorgan	345,936	0	For
MELLON INVESTMENTS Corp	264,077	0	For
Invesco	0	220,995	Against
SEI	211,331	0	For

Institutional-manager reports, all 100 managers: 96,107,090 for, 1,225,220 against, 25,954,439 unknown. Showing the 25 largest; see all in the interactive database.

7. 2. Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Meeting held September 3, 2024.

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%

FOR: 231,131,143AGAINST: 217,489

Details: description as filed, official tally, votes by 46 asset managers

Description as filed by funds: Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.

NUVATION BIO INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 231,131,143 for, 217,489 against — passed, per its Form 8-K filed September 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 47,017,351 for.

FOR

FOR: 47,017,351

Largest asset managers voting on “Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.” at NUVATION BIO INC., 2024-2025
Asset manager	For	Vote
Fidelity	21,071,540	For
Vanguard	9,999,264	For
BlackRock	8,255,183	For
TIAA	1,643,608	For
Charles Schwab	1,347,201	For
Dimensional	830,105	For
Federated Hermes	361,146	For
QUANTITATIVE MASTER SERIES LLC	357,839	For
State Street	305,855	For
American Century	269,297	For
Nationwide	252,495	For
Equitable	235,530	For
Columbia Threadneedle	234,030	For
Lincoln Financial	220,418	For
SEI	139,240	For
Northern Trust	137,534	For
Thrivent	107,961	For
Global X	98,817	For
AIG/SunAmerica	96,552	For
ETF Series Solutions	89,606	For
Invesco	82,454	For
Pacific Life	81,819	For
T. Rowe Price	81,560	For
Bridge Builder Trust	81,302	For
John Hancock	78,125	For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

8. 2. Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Meeting held May 21, 2025.

99.4% Approved · of votes cast

FOR 99.4%

FOR: 279,883,301AGAINST: 1,561,729

Details: description as filed, official tally, votes by 38 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

NUVATION BIO INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 279,883,301 for, 1,561,729 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 38 asset managers below reported 57,187,368 for, 8,937 abstained.

FOR

FOR: 57,187,368ABSTAIN: 8,937

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.” at NUVATION BIO INC., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	31,632,827	0	For
Vanguard	14,976,973	0	For
BlackRock	4,633,168	0	For
Charles Schwab	1,898,919	0	For
Dimensional	1,030,309	0	For
Equitable	514,962	0	For
American Century	448,690	0	For
TIAA	407,068	0	For
Northern Trust	301,765	0	For
SEI	210,185	0	For
Invesco	172,341	0	For
Lincoln Financial	134,500	0	For
Global X	108,429	0	For
Pacific Life	91,871	0	For
ProShares	80,215	0	For
ETFis Series Trust I	62,421	0	For
ETF Series Solutions	51,266	0	For
Brighthouse	41,862	8,937	Mixed
John Hancock	42,525	0	For
State Street	36,970	0	For
Direxion Shares ETF Trust	33,576	0	For
Nationwide	31,679	0	For
Jackson National	29,713	0	For
DWS	28,322	0	For
MASTER INVESTMENT PORTFOLIO	27,709	0	For

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

Largest NUVATION BIO INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 248,624,729 shares outstanding at the time of that meeting.

Fund voting reports: top NUVATION BIO INC. shareholders by shares voted on “To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	8.48%
2	Vanguard	4.02%
3	BlackRock	3.32%
4	TIAA	0.76%
5	Charles Schwab	0.54%
6	Dimensional	0.33%
7	Equitable	0.17%
8	Federated Hermes	0.15%
9	QUANTITATIVE MASTER SERIES LLC	0.14%
10	State Street	0.12%

Institutional-manager reports: top NUVATION BIO INC. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	11.65%
2	EcoR1 Capital, LLC	5.57%
3	BlackRock	1.93%
4	GEODE CAPITAL MANAGEMENT, LLC	1.60%
5	ABRAMS CAPITAL MANAGEMENT, L.P.	1.53%
6	Octagon Capital Advisors LP	1.20%
7	State Street	1.08%
8	Aisling Capital Management LP	1.02%
9	Citadel	0.78%
10	Nuveen	0.76%

Reported NUVATION BIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

NUVATION BIO INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
David Hung, M.D.	23.84%	DEF14A
FMR (Fidelity)	20.35%	13F
Entities affiliated with FMR LLC	18.21%	DEF14A
Entities affiliated with Decheng Anbio Limited	10.44%	DEF14A
Min Cui, Ph.D.	10.44%	DEF14A
BlackRock	7.43%	13F
Vanguard Group	6.19%	13F
Geode Capital	2.06%	13F
State Street	1.95%	13F
Millennium Management	1.52%	13F

Percentages above are of 248,624,729 shares outstanding, as reported by NUVATION BIO INC. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NUVATION BIO INC.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At NUVATION BIO INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held September 3, 2024 and May 21, 2025), 169 asset managers reported how they voted on 8 ballot items in their SEC Form N-PX filings, covering 1,472 separate fund positions. On the most widely held item of the season, voted at the meeting held September 3, 2024 — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS… — NUVATION BIO INC.'s filing reports the proposal as approved, with 99.1% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NUVATION BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 5, 2024.

NUVATION BIO INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.